Adding Chinese herbal medicine to conventional therapy brings cognitive benefits to patients with Alzheimer's disease: a retrospective analysis.

作者: Jing Shi , Jingnian Ni , Tao Lu , Xuekai Zhang , Mingqing Wei

DOI: 10.1186/S12906-017-2040-5

关键词:

摘要: Conventional therapy (CT) such as donepezil and memantine are well-known short-term treatments for the symptoms of Alzheimer’s disease (AD). The efficacy them, however, drops below baseline level after 9 months. In China, herbal a complementary is very popular. Should conventional combined with (CT + H) make add-on benefit? this retrospective cohort study, 344 outpatients diagnosed probable dementia due to AD were collected, treatment either CT + H or CT alone in clinical settings. All patients examined coronary MRI scan. Cognitive functions obtained by mini–mental state examination (MMSE) every 3 months longest follow-up 24 months. Most initially mild (MMSE = 21–26, n = 177) moderate (MMSE = 10–20, n = 137) dementia. At 18 months, CT+ H scored on average 1.76 (P = 0.002) better than patients, at 24 months, 2.52 (P < 0.001) better. improved cognitive function (△MMSE ≥ 0) was more (33.33% vs 7.69%, P = 0.020). Interestingly, received most robust benefit from therapy. deterioration largely prevented 24 months (ΔMMSE = −0.06), significant improvement (ΔMMSE = −2.66, P = 0.005). Compared alone, significantly benefited patients. A symptomatic effect pronounced time. decline substantially decelerated severity, while stabilized severity over two years. These results imply that Chinese medicines may provide an alternative additive AD.

参考文章(25)
Jingnian Ni, Jing Shi, Mingqing Wei, Jinzhou Tian, Wenjia Jian, Jianping Liu, Tonghua Liu, Binglin Liu, Screening mild cognitive impairment by delayed story recall and instrumental activities of daily living International Journal of Geriatric Psychiatry. ,vol. 30, pp. 888- 890 ,(2015) , 10.1002/GPS.4317
Gordon Wilcock, Ian Howe, Hilary Coles, Sean Lilienfeld, Luc Truyen, Young Zhu, Roger Bullock, A Long-Term Comparison of Galantamine and Donepezil in the Treatment of Alzheimer’s Disease Drugs & Aging. ,vol. 20, pp. 777- 789 ,(2003) , 10.2165/00002512-200320100-00006
Shu-Yuan WANG, Ji-Ping LIU, Wei-Wei JI, Wen-Jiao CHEN, Qiang FU, Liang FENG, Shi-Ping MA, Qifu-Yin attenuates AGEs-induced Alzheimer-like pathophysiological changes through the RAGE/NF-κB pathway Chinese Journal of Natural Medicines. ,vol. 12, pp. 920- 928 ,(2014) , 10.1016/S1875-5364(14)60135-7
B. Winblad, A. Wimo, K. Engedal, H. Soininen, F. Verhey, G. Waldemar, A.-L. Wetterholm, A. Haglund, R. Zhang, R. Schindler, 3-Year Study of Donepezil Therapy in Alzheimer’s Disease: Effects of Early and Continuous Therapy Dementia and Geriatric Cognitive Disorders. ,vol. 21, pp. 353- 363 ,(2006) , 10.1159/000091790
Marco Canevelli, Nawal Adali, Eirini Kelaiditi, Christelle Cantet, Pierre-Jean Ousset, Matteo Cesari, Effects of Gingko biloba supplementation in Alzheimer's disease patients receiving cholinesterase inhibitors: Data from the ICTUS study Phytomedicine. ,vol. 21, pp. 888- 892 ,(2014) , 10.1016/J.PHYMED.2014.01.003
Ralf Ihl, Lutz Frölich, Thomas Dierks, Eva-Maria Martin, Konrad Maurer, Differential validity of psychometric tests in dementia of the Alzheimer type Psychiatry Research. ,vol. 44, pp. 93- 106 ,(1992) , 10.1016/0165-1781(92)90044-4
Jia Liu, Lu-ning Wang, Jin-zhou Tian, Recognition of dementia in ancient China Neurobiology of Aging. ,vol. 33, pp. 2948.e11- 2948.e13 ,(2012) , 10.1016/J.NEUROBIOLAGING.2012.06.019
Martin Farlow, Ravi Anand, John Messina Jr, Richard Hartman, Jeffrey Veach, A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease. European Neurology. ,vol. 44, pp. 236- 241 ,(2000) , 10.1159/000008243
Kit Yee Chan, Wei Wang, Jing Jing Wu, Li Liu, Evropi Theodoratou, Josip Car, Lefkos Middleton, Tom C Russ, Ian J Deary, Harry Campbell, Igor Rudan, None, Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990-2010: a systematic review and analysis The Lancet. ,vol. 381, pp. 2016- 2023 ,(2013) , 10.1016/S0140-6736(13)60221-4